Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Flurazepam hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for flurazepam hydrochloride and what is the scope of freedom to operate?

Flurazepam hydrochloride
is the generic ingredient in two branded drugs marketed by Watson Labs, Hikma Intl Pharms, Halsey, Hikma Pharms Llc, Aurolife Pharma Llc, Valeant Pharm Intl, Purepac Pharm, Par Pharm, Mylan Pharms Inc, Sun Pharm Inds, Superpharm, Usl Pharma, and Warner Chilcott, and is included in twenty-three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for flurazepam hydrochloride. Ten suppliers are listed for this compound.

Summary for Generic Name: flurazepam hydrochloride

Drug Master File Entries: see list4
Suppliers / Packagers: see list10
Bulk Api Vendors: see list27
Clinical Trials: see list988
Patent Applications: see list5,189
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:flurazepam hydrochloride at DailyMed

Pharmacology for Ingredient: flurazepam hydrochloride

Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
flurazepam hydrochloride
CAPSULE;ORAL071205-001Nov 25, 1986DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
flurazepam hydrochloride
CAPSULE;ORAL070345-002Nov 27, 1985RXNoNo► Subscribe► Subscribe
Usl Pharma
flurazepam hydrochloride
CAPSULE;ORAL070562-001Jul 9, 1987DISCNNoNo► Subscribe► Subscribe
Par Pharm
flurazepam hydrochloride
CAPSULE;ORAL070445-001Mar 20, 1986DISCNNoNo► Subscribe► Subscribe
Purepac Pharm
flurazepam hydrochloride
CAPSULE;ORAL071551-001Sep 9, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus